Gene Therapy & Gene Editing
Part of Healthcare - Genomics & Precision Medicine
 VRTX | Vertex Pharmaceuticals Inc | $126.1b | $486.51 | -0.1% | 776.5K |
 REGN | Regeneron Pharmaceuticals Inc | $65.4b | $676.50 | -0.3% | 479.2K |
 INSM | Insmed, Inc. | $23.1b | $109.04 | +0.8% | 1.7M |
 BMRN | BioMarin Pharmaceuticals Inc | $11.1b | $58.50 | -0.7% | 1.0M |
 KRYS | Krystal Biotech, Inc. Common Stock | $11.0b | $354.52 | +3.8% | 263.6K |
 CRSP | CRISPR Therapeutics AG | $5.4b | $47.87 | -1.6% | 1.4M |
 FOLD | Amicus Therapeutics, Inc | $4.5b | $14.49 | +0.0% | 3.5M |
 BEAM | Beam Therapeutics Inc. Common Stock | $3.5b | $28.14 | -3.0% | 1.6M |
 QURE | uniQure N.V. | $3.2b | $40.65 | +2.3% | 853.4K |
 NTLA | Intellia Therapeutics, Inc | $2.4b | $11.51 | -4.1% | 3.8M |
 VCEL | Vericel Corporation | $2.3b | $46.63 | -2.4% | 375.2K |
 PGEN | Precigen, Inc. Common Stock | $2.0b | $5.00 | 0.0% | 2.6M |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | $2.0b | $6.12 | -0.3% | 2.4M |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | $1.9b | $17.30 | -0.2% | 2.3M |
 BLFS | BioLife Solutions Inc. | $1.4b | $29.14 | -3.8% | 1.3M |
 MGTX | MeiraGTx Holdings plc Ordinary Shares | $1.3b | $12.44 | +0.7% | 369.5K |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.0b | $25.61 | -0.0% | 295.3K |
 SLDB | Solid Biosciences Inc. Common Stock | $1.0b | $9.25 | -3.8% | 1.3M |
 SANA | Sana Biotechnology, Inc. Common Stock | $1.0b | $3.15 | -1.1% | 2.3M |
 DSGN | Design Therapeutics, Inc. Common Stock | $0.9b | $12.57 | -0.2% | 370.1K |
 CYRX | CryoPort, Inc. Common Stock | $0.8b | $16.50 | +0.1% | 613.8K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.7b | $1.80 | +0.8% | 4.5M |
 FDMT | 4D Molecular Therapeutics, Inc. Common Stock | $0.7b | $10.92 | +1.3% | 472.7K |
 PRME | Prime Medicine, Inc. Common Stock | $0.7b | $3.22 | -2.8% | 2.9M |
 RGNX | REGENXBIO Inc. | $0.6b | $9.84 | -11.9% | 7.1M |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $0.5b | $7.50 | 0.0% | 783.1K |
 OCGN | Ocugen, Inc. Common Stock | $0.5b | $1.35 | -0.7% | 3.5M |
 CABA | Cabaletta Bio, Inc. Common Stock | $0.5b | $2.83 | +6.9% | 3.1M |
 EDIT | Editas Medicine, Inc. Common Stock | $497.2m | $2.97 | +3.1% | 1.6M |
 NGNE | Neurogene, Inc. Common Stock | $497.0m | $37.38 | +2.5% | 452.5K |
 BNTC | Benitec Biopharma Inc. Common Stock | $459.7m | $12.80 | +1.1% | 68.4K |
 RCKT | Rocket Pharmaceuticals, Inc. Common Stock | $373.4m | $3.41 | +0.6% | 1.3M |
 LXEO | Lexeo Therapeutics, Inc. Common Stock | $365.5m | $4.58 | +2.6% | 637.3K |
 ABEO | Abeona Therapeutics Inc. Common Stock | $352.2m | $6.96 | -0.4% | 708.0K |
 IRD | Opus Genetics, Inc. Common Stock | $339.3m | $3.21 | -0.6% | 447.8K |
 TRDA | Entrada Therapeutics, Inc. Common Stock | $285.7m | $6.88 | -0.1% | 342.2K |
 VYGR | Voyager Therapeutics, Inc. Common Stock | $211.5m | $3.08 | +4.3% | 864.7K |
 DTIL | Precision BioSciences, Inc. Common Stock | $202.8m | $7.86 | -5.5% | 254.3K |
 KRRO | Korro Bio, Inc. Common Stock | $190.1m | $12.22 | -0.2% | 148.5K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $174.6m | $1.69 | -0.6% | 1.3M |
 TNYA | Tenaya Therapeutics, Inc. Common Stock | $160.4m | $0.80 | -3.6% | 1.7M |
 GNLX | Genelux Corporation Common Stock | $135.0m | $2.87 | +1.8% | 73.8K |
 MXCT | MaxCyte, Inc. Common Stock | $131.8m | $1.25 | -8.1% | 720.0K |
 ENGN | enGene Therapeutics Inc. Common Stock | $115.9m | $1.82 | -4.7% | 785.8K |
 CBUS | Cibus, Inc. Class A Common Stock | $104.6m | $1.83 | -1.1% | 199.1K |
 INO | Inovio Pharmaceuticals, Inc. | $90.5m | $1.13 | 0.0% | 806.0K |
 SGMO | Sangamo Therapeutics, Inc. Common Stock | $83.3m | $0.18 | -17.5% | 6.9M |
 TCRX | TScan Therapeutics, Inc. Common Stock | $64.1m | $0.92 | +1.4% | 140.8K |
 TIL | Instil Bio, Inc. Common Stock | $52.2m | $7.43 | -0.8% | 8.5K |
 MGX | Metagenomi Therapeutics, Inc. Common Stock | $44.8m | $1.24 | -0.4% | 126.2K |